Obsidio™ Conformable Embolic Registry

Clinical trial NCT06170619 · COMPLETED

Trial details

NCT number: NCT06170619
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Hypervascular Tumors Bleeding Hemorrhage

Start date: 2024-06-19
Primary completion: 2025-09-09
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.